Fresenius, NxStage Postpone Merger End Date Due to Shutdown
January 29 2019 - 8:46AM
Dow Jones News
By Donato Paolo Mancini
Fresenius Medical Care AG & Co. KGaA (FME.XE) and NxStage
Medical Inc. (NXTM) have extended their merger agreement end date
due to the U.S. government shutdown, Fresenius said Tuesday.
The move is to account for the interruption of the Federal Trade
Commission's review of the transaction during the recent
shutdown.
The merger date has been moved to Aug. 6, 2019, or to an earlier
date for which the FTC will have been fully funded for 60
consecutive days, Germany's Fresenius said.
Write to Donato Paolo Mancini at
donatopaolo.mancini@dowjones.com; @donatopmancini
(END) Dow Jones Newswires
January 29, 2019 08:31 ET (13:31 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Nxstage Medical (NASDAQ:NXTM)
Historical Stock Chart
From May 2024 to Jun 2024
Nxstage Medical (NASDAQ:NXTM)
Historical Stock Chart
From Jun 2023 to Jun 2024